Zhou, H., Meng, J., Malerba, A., Catapano, F., Sintusek, P., Jarmin, S., . . . Muntoni, F. (2020). Myostatin inhibition in combination with antisense oligonucleotide therapy improves outcomes in spinal muscular atrophy. J Cachexia Sarcopenia Muscle.
Chicago Style CitationZhou, Haiyan, et al. "Myostatin Inhibition in Combination With Antisense Oligonucleotide Therapy Improves Outcomes in Spinal Muscular Atrophy." J Cachexia Sarcopenia Muscle 2020.
MLA CitationZhou, Haiyan, et al. "Myostatin Inhibition in Combination With Antisense Oligonucleotide Therapy Improves Outcomes in Spinal Muscular Atrophy." J Cachexia Sarcopenia Muscle 2020.
Warning: These citations may not always be 100% accurate.